470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

Por Overcash, J Scott, O’Riordan, William, Quintas, Megan, Lawrence, Laura, Tseng, Carol, Cammarata, Sue
Publicado no Open Forum Infect Dis (2019)

1479. Clinical Efficacy and Safety Analysis Evaluating Oral Gepotidacin (GSK2140944) from a Phase IIa Study in the Treatment of Uncomplicated Urinary Tract Infections

Por Overcash, J Scott, Dumont, Etienne, Perry, Caroline R, Tiffany, Courtney, Scangarella-Oman, Nicole, Raychaudhuri, Aparna, Hossain, Mohammad
Publicado no Open Forum Infect Dis (2019)

Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study

Por Overcash, J. Scott, Bhiwandi, Pouru, Garrity-Ryan, Lynne, Steenbergen, Judith, Bai, Stephen, Chitra, Surya, Manley, Amy, Tzanis, Evan
Publicado no Antimicrob Agents Chemother (2019)

Bone and Joint Tissue Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery

Por Menetrey, Annick, Janin, Annick, Pullman, John, Overcash, J. Scott, Haouala, Amina, Leylavergne, François, Turbe, Laurent, Wittke, Frederick, Nicolas-Métral, Valérie
Publicado no Antimicrob Agents Chemother (2019)

Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection

Por Lawitz, Eric J., O'Riordan, William D., Asatryan, Armen, Freilich, Bradley L., Box, Terry D., Overcash, J. Scott, Lovell, Sandra, Ng, Teresa I., Liu, Wei, Campbell, Andrew, Lin, Chih-Wei, Yao, Betty, Kort, Jens
Publicado no Antimicrob Agents Chemother (2016)